Serum

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2019 Financial Results

Retrieved on: 
Tuesday, October 15, 2019
Medicine, Medical tests, Clinical medicine, Blood tests, Diabetes, Blood, Serum, Glycated hemoglobin, Branches of biology

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market.

Key Points: 
  • Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market.
  • The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood.
  • Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.
  • For further information please see the Company's website: www.trinitybiotech.com .

Perricone MD Unveils Next Generation Polyamine Technology - High Potency Growth Factor Firming & Lifting Serum

Retrieved on: 
Monday, October 7, 2019
Blood, Serum, Nicholas Perricone, Health

Harnessing the power of a recently developed proprietary polyamine technology, Perricone MD unveils its High Potency Growth Factor Firming & Lifting Serum.

Key Points: 
  • Harnessing the power of a recently developed proprietary polyamine technology, Perricone MD unveils its High Potency Growth Factor Firming & Lifting Serum.
  • Giving retinol the ability to be slowly released over time, High Potency Growth Factor Firming & Lifting Serum has both immediate and long-term skin benefits.
  • "After many dedicated years of research and development, we've brought the High Potency Growth Factor Firming & Lifting Serum to market with a combination of proprietary polyamine growth factor and other key sciences," says Dr. Perricone.
  • High Potency Growth Factor Firming & Lifting Serum is a day and night treatment and can be used on all skin types.

Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology

Retrieved on: 
Monday, September 30, 2019
Medical specialties, Branches of biology, Blood, Serum, Biology, Antibody, Vaccine

Moving forward, Aridis is eligible for future milestone payments for achieving product development and commercial objectives, along with royalties on net sales.

Key Points: 
  • Moving forward, Aridis is eligible for future milestone payments for achieving product development and commercial objectives, along with royalties on net sales.
  • MabIgX is Aridis' proprietary technology platform to rapidly identify rare, potent antibody-producing B-cells from directly from convalescent patients.
  • About Serum Institute of India, Ltd.
    Serum Institute of India Pvt.
  • It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute.

Global Bovine Serum Albumin Market by Form, Grade, End-user, and Region - Forecast to 2025

Retrieved on: 
Thursday, August 29, 2019
Blood proteins, Serum albumin, Albumin, Serum, Bovine serum albumin, Draft:Albumin transport function analysis by EPR spectroscopy

DUBLIN, Aug. 29, 2019 /PRNewswire/ -- The "Bovine Serum Albumin Market by Form (Dry, Liquid), Grade (Technical-& Diagnostic-Grade, Research/Reagent-Grade, Food Grade), End User (Life Sciences Industry, Feed Industry, Food Industry, Research Institutes), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 29, 2019 /PRNewswire/ -- The "Bovine Serum Albumin Market by Form (Dry, Liquid), Grade (Technical-& Diagnostic-Grade, Research/Reagent-Grade, Food Grade), End User (Life Sciences Industry, Feed Industry, Food Industry, Research Institutes), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • This report segments the bovine serum albumin market on the basis of form, grade, end-user, method of preparation, and region.
  • The global bovine serum albumin market is estimated to be valued at USD 255 million in 2019 and is projected to reach USD 304 million by 2025, recording a CAGR of 3%.
  • In 2019, Germany is estimated to hold the largest market share due to the growing in-vitro diagnostics market in the country.

Global $300M+ Bovine Serum Albumin Market, 2025: Technical & Diagnostic-Grade Segment to Witness the Fastest Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 29, 2019
Health, Pharmaceutical, Blood proteins, Branches of biology, Biology, Medical specialties, Bovine serum albumin, Serum albumin, Albumin, Immunoassay, BSA, Serum, Obesity, Dietary supplement

The global bovine serum albumin market is estimated to be valued at USD 255 million in 2019 and is projected to reach USD 304 million by 2025, recording a CAGR of 3%.

Key Points: 
  • The global bovine serum albumin market is estimated to be valued at USD 255 million in 2019 and is projected to reach USD 304 million by 2025, recording a CAGR of 3%.
  • Since obesity is a growing problem, the manufacturers are looking at cost-effective solutions for the production of dietary supplements.
  • The technical- & diagnostic-grade is projected to witness fast growth due to its widespread application in areas such as cell culture and immunoassay preparation.
  • The technical- & diagnostic-grade of BSA is most recommended for biotechnology applications such as immunodetections as a blocking and saturating agent.

Q-Sera’s Innovative Blood Clotting Technology Granted Patent in US

Retrieved on: 
Tuesday, August 20, 2019
Health, Medical devices, General Health, Pharmaceutical, Biotechnology, Hematology, Medical specialties, Medicine, Anatomy, Venipuncture, Serum, Blood, Thrombus

Medical device company Q-Sera Pty Ltd today announces that it has received a Notice of Allowance from the United States Patent & Trademark Office for the foundation patent of its innovative blood clotting technology for use in blood collection tubes.

Key Points: 
  • Medical device company Q-Sera Pty Ltd today announces that it has received a Notice of Allowance from the United States Patent & Trademark Office for the foundation patent of its innovative blood clotting technology for use in blood collection tubes.
  • Having access to a technology that universally clots all blood samples within 5 minutes will contribute to improved patient outcomes and reduced healthcare costs.
  • Q-Sera is delighted with this tremendous milestone, as it underlines the value of our technology as a universal blood collection tube to produce high-quality serum.
  • Q-Seras technology now has patent protection for use in blood collection tubes in the United States, Europe, Japan, China, Mexico, Russia, Canada, South Africa and Australia.

Bovine Serum Albumin Market Worth $304 Million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, August 13, 2019
Blood proteins, Serum, Albumin, Bovine serum albumin

Factors such as the inexpensive and stable nature of bovine serum albumin as a protein standard, growing demand for blood-based products are some of the factors driving the growth of the market.

Key Points: 
  • Factors such as the inexpensive and stable nature of bovine serum albumin as a protein standard, growing demand for blood-based products are some of the factors driving the growth of the market.
  • The technical-& diagnostic-grade, by grade, is estimated to account for the largest market share, by value, in 2019
    This segment holds the largest market share in the bovine serum albumin market since it has a widespread application in the pharmaceutical and diagnostic industries.
  • This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the bovine serum albumin market.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".

Bovine Serum Albumin Market Worth $304 Million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, August 13, 2019
Blood proteins, Serum, Albumin, Bovine serum albumin

Factors such as the inexpensive and stable nature of bovine serum albumin as a protein standard, growing demand for blood-based products are some of the factors driving the growth of the market.

Key Points: 
  • Factors such as the inexpensive and stable nature of bovine serum albumin as a protein standard, growing demand for blood-based products are some of the factors driving the growth of the market.
  • The technical-& diagnostic-grade, by grade, is estimated to account for the largest market share, by value, in 2019
    This segment holds the largest market share in the bovine serum albumin market since it has a widespread application in the pharmaceutical and diagnostic industries.
  • This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the bovine serum albumin market.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".

Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay

Retrieved on: 
Tuesday, July 23, 2019
Branches of biology, Medicine, Biology, Immunologic tests, Cytoskeleton, Neurofilament, Immunoassay, Serum, Antibody

MINNEAPOLIS, July 23, 2019 /PRNewswire/ --Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple-branded Ella immunoassay platform.

Key Points: 
  • MINNEAPOLIS, July 23, 2019 /PRNewswire/ --Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple-branded Ella immunoassay platform.
  • Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use in its proprietary Simple Plex immunoassays on Ella.
  • Nf-L has been implicated as an important biomarker signature for several neuromuscular and neurodegenerative diseases.
  • Detecting Nf-L in serum and plasma samples is challenging as the marker is present at low picogram levels.

Global Cell Culture (Media, Sera, Reagents) Market Report 2012-2022 with Profiles of 28 Key Companies

Retrieved on: 
Monday, January 14, 2019
Biology, Biotechnology, Nature, Cell biology, Cell culture, Blood, Alternatives to animal testing, Chemically defined medium, Serum, Growth medium, Fetal bovine serum, Miltenyi Biotec

Growth in the use of cell culture for biological research, vaccine production, the production of therapeutic proteins, and emerging regenerative medicine applications are driving the global cell culture market.

Key Points: 
  • Growth in the use of cell culture for biological research, vaccine production, the production of therapeutic proteins, and emerging regenerative medicine applications are driving the global cell culture market.
  • Market data provided in Global Cell Culture Markets include:
    Global Cell Culture Market by Segment, 2012-2022 (mil US$) (Media, Sera, Reagents, Total)
    Global Cell Culture Market by Region/Country, 2017 (North America, Europe, UK/Ireland, Singapore/Malaysia, Japan, Korea, China, Rest of World)
    Global Cell Culture Market by Region/Country, 2022 (North America, Europe, UK/Ireland, Singapore/Malaysia, Japan, Korea, China, Rest of World)
    Cell Culture Market Share by Company, 2017
    The most significant recent trend in media is a shift from serum- and animal-component-containing media to serum-free and chemically defined media.
  • The report provides the following media market data:
    Global Cell Culture Media Market, 2012 - 2022 (mil US$)
    Global Cell Culture Media Market by Type, 2017 (%) (Serum-Free, Chemically Defined, Animal-Free)
    Global Cell Culture Media Market by Type, 2022 (%) (Serum-Free, Chemically Defined, Animal-Free)
    Serum has traditionally been used as the major supplement to cell culture media.
  • The report provides the following sera market data:
    Global Cell Culture Sera Market, 2012-2022 (mil US$)
    Global Cell Culture Sera by Type, 2017 (%) (Serum-Free, Chemically Defined, Animal-Free)
    Global Cell Culture Sera by Type, 2022 (%) (Serum-Free, Chemically Defined, Animal-Free)
    The reagents segment of the cell culture market is driven by their increasing use in biotherapeutics research and production.